Literature DB >> 9321833

Inducible PDGF A-chain transcription in smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3.

E S Silverman1, L M Khachigian, V Lindner, A J Williams, T Collins.   

Abstract

Platelet-derived growth factor (PDGF) A-chain is expressed by vascular smooth muscle cells (SMC) in a variety of pathological settings. Phorbol 12-myristate 13-acetate (PMA) increases A-chain transcription and was used as a model agonist. Transient transfection analysis identified a region in the promoter that is required for inducibility, located between base pairs -71 and -55 from the transcription start site. This region contains overlapping recognition elements for members of the Sp and Egr families. Egr-1 transcript and protein increased after PMA treatment, whereas Sp1 and Sp3 levels remain unchanged. Egr-1 expression and PDGF A-chain promoter activity also increased in cells exposed to PDGF or mechanical injury. In vitro binding assays demonstrated that Egr-1, Sp1, and Sp3 can bind to this promoter region and that increasing Egr-1 can displace both Sp1 and Sp3. In an in vivo model of arterial injury, Egr-1 expression was induced concurrently with the expression of PDGF-A in SMC. Displacement of Sp1 and Sp3 by Egr-1 is correlated with inducible PDGF A-chain expression in the vessel wall.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9321833     DOI: 10.1152/ajpheart.1997.273.3.H1415

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  30 in total

1.  NAB2: a transcriptional brake for activated gene expression in the vessel wall?

Authors:  J M Miano; B C Berk
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 2.  Pathways of Egr-1-mediated gene transcription in vascular biology.

Authors:  E S Silverman; T Collins
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

Review 3.  Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.

Authors:  L M Khachigian
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

4.  Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury.

Authors:  C P Regan; P J Adam; C S Madsen; G K Owens
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

5.  Expression of Egr-1 in late stage emphysema.

Authors:  W Zhang; S D Yan; A Zhu; Y S Zou; M Williams; G C Godman; B M Thomashow; M E Ginsburg; D M Stern; S F Yan
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 6.  Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis.

Authors:  Florian Blaschke; Dennis Bruemmer; Ronald E Law
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

7.  Molecular cloning of the human platelet-derived growth factor receptor beta (PDGFR-beta) promoter and drug targeting of the G-quadruplex-forming region to repress PDGFR-beta expression.

Authors:  Yong Qin; Jessica S Fortin; Denise Tye; Mary Gleason-Guzman; Tracy A Brooks; Laurence H Hurley
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

8.  The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells.

Authors:  Vladimír Cermák; Jan Kosla; Jirí Plachý; Katerina Trejbalová; Jirí Hejnar; Michal Dvorák
Journal:  Cell Mol Life Sci       Date:  2010-05-28       Impact factor: 9.261

9.  NF1/X represses PDGF A-chain transcription by interacting with Sp1 and antagonizing Sp1 occupancy of the promoter.

Authors:  Louise A Rafty; Fernando S Santiago; Levon M Khachigian
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

10.  cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1).

Authors:  E S Silverman; J Du; A J Williams; R Wadgaonkar; J M Drazen; T Collins
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.